Evotec Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| IQV | IQVIA Holdings | Outperform |
15
|
$223.37 | $267.27 | 23.11% | 19 | $40.70B |
| IDXX | IDEXX Laboratories | Outperform |
14
|
$480.60 | $583.92 | 21.72% | 0 | $39.69B |
| ICLR | ICON Public | Buy |
16
|
$309.02 | $306.07 | 16.50% | 1 | $25.55B |
| ARGX | argenx | Outperform |
4
|
358.60€ | 531.81€ | 22.14% | 10 | 21.30€B |
| GMAB | Genmab A/S | Outperform |
16
|
kr2.06k | kr2.71k | 28.09% | 14 | kr133.28B |
| SRT3 | Sartorius | Outperform |
18
|
284.30€ | 281.57€ | 16.95% | 10 | 17.53€B |
| SGSN | SGS | Hold |
18
|
CHF82.36 | CHF86.34 | 9.28% | 7 | CHF15.59B |
| LH | Laboratory Corp of America Hol... | Outperform |
11
|
$201.32 | $241.28 | 20.21% | 9 | $16.97B |
| DGX | Quest Diagnostics | Outperform |
10
|
$137.38 | $141.17 | 5.55% | 8 | $15.26B |
| BVI | Bureau Veritas | Outperform |
18
|
27.70€ | 26.96€ | 11.91% | 12 | 12.44€B |
| MEDP | Medpace Holdings | Outperform |
14
|
$392.57 | $281.20 | 15.14% | 2 | $12.01B |
| ERF | Eurofins Scientific | Hold |
18
|
56.68€ | 0.00€ | 5.86% | 5 | 11.11€B |
| CRL | Charles River Laboratories Int... | Outperform |
16
|
$233.47 | $229.97 | 18.54% | 11 | $11.76B |
| REC | Recordati Industria Chimica e ... | Hold |
18
|
50.75€ | 48.61€ | 1.38% | 1 | 10.30€B |
| CTLT | Catalent | Hold |
15
|
$56.50 | $49.29 | 12.39% | 3 | $10.23B |
| ITRK | Intertek Group | Outperform |
18
|
£49.56 | £44.87 | 6.54% | 14 | £7.97B |
| SHL | Sonic Healthcare | Hold |
18
|
$26.12 | $34.12 | 18.68% | 0 | $12.86B |
| BANB | Bachem Holding | Hold |
16
|
CHF80.35 | CHF616.00 | -0.44% | 2 | CHF6.02B |
| ZEAL | Zealand Pharma A/S | Outperform |
8
|
kr622.50 | kr357.00 | 30.92% | 2 | kr39.42B |
| ABCM | Abcam | - |
18
|
$23.99 | $19.25 | -67.15% | 0 | $5.52B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.60 | £28.11 | 49.03% | 9 | £4.35B |
| ORNBV | Orion Oyj | Hold |
14
|
36.12€ | 42.52€ | 16.28% | 3 | 5.04€B |
| ALK B | ALK-Abelló A/S | Outperform |
13
|
kr148.80 | kr109.25 | 10.89% | 3 | kr32.91B |
| TECN | Tecan Group | Outperform |
18
|
CHF326.60 | CHF406.33 | 22.47% | 3 | CHF4.19B |
| MOR | MorphoSys | Hold |
6
|
66.65€ | 28.78€ | 2.03% | 3 | 2.49€B |
| SYNH | Syneos Health | - |
16
|
$42.98 | $43.00 | -100.00% | 0 | $2.64B |
| INDV | Indivior PLC | Buy |
14
|
£14.35 | £28.89 | 115.54% | 4 | £1.95B |
| GLPG | Galapagos NV | Hold |
6
|
26.98€ | 39.85€ | 29.73% | 2 | 1.80€B |
| ALM | Almirall | Outperform |
16
|
8.69€ | 11.39€ | 26.58% | 3 | 1.79€B |
| APPS | Applus Services | Outperform |
15
|
12.68€ | 10.92€ | -9.70% | 3 | 1.63€B |
| CLIN | Clinigen | - |
18
|
£9.25 | £7.78 | -100.00% | 0 | £1.23B |
| BIO3 | Biotest | Hold |
9
|
28.60€ | 37.00€ | 29.37% | 0 | 1.40€B |
| COPN | Cosmo Pharmaceuticals N.V. | Buy |
12
|
CHF72.20 | CHF76.55 | 29.58% | 0 | CHF1.16B |
| VEC | Vectura Group | - |
14
|
£165.00 | £1.55 | -100.00% | 0 | £1.00B |
| FAE | Faes Farma | Hold |
18
|
3.45€ | 3.90€ | 5.80% | 0 | 1.06€B |
| 4544 | H.U. Group Holdings | Outperform |
17
|
¥2.69k | ¥0.00 | -7.05% | 0 | ¥164.15B |
| ERGO | Ergomed | - |
16
|
£9.84 | £14.90 | -100.00% | 0 | £490.82M |
| PHM | Pharma Mar | Outperform |
13
|
31.14€ | 50.20€ | 54.14% | 1 | 536.95€M |
| BSLN | Basilea Pharmaceutica | Outperform |
6
|
CHF39.90 | CHF65.63 | 65.41% | 0 | CHF474.13M |
| NIOX | NIOX Group Plc | Buy |
6
|
£0.70 | £0.76 | 10.00% | 0 | £301.02M |
| DBV | DBV Technologies | Outperform |
5
|
1.20€ | 4.07€ | 233.33% | 1 | 119.69€M |
| MOLN | Molecular Partners | Outperform |
4
|
CHF3.40 | CHF9.50 | 175.00% | 1 | CHF110.77M |